Törnebrandt K, Nobin A, Owman C
Peptides. 1987 Mar-Apr;8(2):251-6. doi: 10.1016/0196-9781(87)90099-4.
Neuropeptide Y (NPY), substance P (SP), vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP), lysyl-bradykinin, somatostatin, Met- and Leu-enkephalin were tested for their smooth muscle activity in isolated human mesenteric arteries and veins. Only NPY regularly contracted both arteries and veins. Alpha-adrenergic and 5-HT2 antagonists did not affect the response. Somatostatin contracted the veins, but not the arteries, in a variable but concentration-dependent way. The other neuropeptides were without contractile effect. CGRP, bradykinin, and SP regularly dilated, in a concentration-dependent way, both arteries and veins precontracted with prostaglandin F2 alpha or uridine triphosphate. CGRP and bradykinin were the most potent dilators. VIP and somatostatin usually caused a moderate dilatation in the arteries, whereas in the veins, somatostatin was without dilatory effect and the VIP-induced dilatation was irregular. In both types of vessels Met-enkephalin seldom gave any significant dilatation, and no response occurred in the presence of Leu-enkephalin or NPY. The SP-antagonist (D-Arg, D-Trp, Leu)-SP (spantide) caused a dextal shift of the concentration-response curves for SP, in the case of the arteries also including a reduced maximum effect.
对神经肽Y(NPY)、P物质(SP)、血管活性肠肽(VIP)、降钙素基因相关肽(CGRP)、赖氨酰缓激肽、生长抑素、甲硫氨酸脑啡肽和亮氨酸脑啡肽在离体人肠系膜动脉和静脉中的平滑肌活性进行了检测。只有NPY能使动脉和静脉都出现规律性收缩。α-肾上腺素能拮抗剂和5-HT2拮抗剂不影响该反应。生长抑素能使静脉收缩,但对动脉无作用,其收缩作用不定但呈浓度依赖性。其他神经肽无收缩作用。CGRP、缓激肽和SP能使预先用前列腺素F2α或三磷酸尿苷预收缩的动脉和静脉呈浓度依赖性地出现规律性舒张。CGRP和缓激肽是最有效的舒张剂。VIP和生长抑素通常能使动脉出现中度舒张,而在静脉中,生长抑素无舒张作用,VIP引起的舒张不规则。在这两种血管中,甲硫氨酸脑啡肽很少引起明显舒张,亮氨酸脑啡肽或NPY存在时无反应。SP拮抗剂(D-Arg,D-Trp,Leu)-SP(spantide)使SP的浓度-反应曲线右移,在动脉中还包括最大效应降低。